Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says

The pause on Johnson & Johnson’s coronavirus vaccine research study, which is due to an adverse reaction by one of the participants, is “quite common” in vaccine clinical trials, Health and Human Services Secretary Alex Azar told “Varney & Co.” on Tuesday.